Surgical Bypass Versus Hybrid Approaches for Critical Limb Ischemia

The present randomized study proposed to compare the immediate postoperative and 2-year clinical outcomes of long surgical bypass and hybrid approaches in patients with multilevel critical lower limb ischemia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Critical Lower Limb Ischemia

Age range

50 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

TASC II type D femoropopliteal lesions with intact ipsilateral femoral pulse.
Fontaine classification stage IV (gangrene or necrosis).
Rutherford grade III and IV category 5 and 6 with salvageable foot

Exclusion criteria

heart failure
liver failure
renal impairment

Treatment and study plan

long surgical bypass

Procedure

long surgical bypass and hybrid approaches in patients with multilevel critical lower limb ischemia.

Hybrid approach

Procedure

Hybrid approach including bypass and endovascular revascularization

Primary outcomes

Late occlusion

Time frame: 2 years

Late occlusion of the affected vessels

Sponsors and collaborators

Lead sponsor

Egyptian Biomedical Research Network

Network

Registry information

Official study title

Long Surgical Bypass Versus Hybrid Approaches for Management of Critical Limb Ischemia

Important dates

Study start: 2014
Primary completion: 2019
Study completion: 2019
First posted: Jul 29, 2020
Registry last updated: Jul 29, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed